About this book series
Biotechnology: Pharmaceutical Aspects focuses on: (i) methodologies used by discovery scientists for characterizing the “drug-like” (physicochemical, ADME, and toxicological) properties of small molecule-based and macromolecule-based hits, leads, and drug candidates; (ii) chemical strategies used to balance and optimize a molecule's “drug-like” and pharmacological (physiological and/or behavioral) properties; and (iii) enabling technologies used to insure the efficient delivery of small molecule-based and macromolecule-based drug candidates to their sites of action in animals and humans. Volumes present a thorough examination of drug dosage and drug dosage forms in use and in development. The series will be particularly helpful to scientists involved in drug development and to the educators who are training the next generation of pharmaceutical scientists.
Book titles in this series
-
-
Optimizing the "Drug-Like" Properties of Leads in Drug Discovery
- Editors:
-
- Ronald Borchardt
- Edward Kerns
- Michael Hageman
- Dhrien Thakker
- Copyright: 2006
Available Renditions
- Hard cover
- Soft cover
- eBook
-
Advances in Bioactivation Research
- Editors:
-
- Adnan Elfarra
- Copyright: 2008
Available Renditions
- Hard cover
- Soft cover
- eBook
-
Drug Absorption Studies
In Situ, In Vitro and In Silico Models
- Editors:
-
- Carsten Ehrhardt
- Kwang-Jin Kim
- Copyright: 2008
Available Renditions
- Hard cover
- Soft cover
- eBook
-
Current Trends in Monoclonal Antibody Development and Manufacturing
- Editors:
-
- Steven J. Shire
- Wayne Gombotz
- Karoline Bechtold-Peters
- James Andya
- Copyright: 2010
Available Renditions
- Hard cover
- Soft cover
- eBook
Abstracted and indexed in
-
- Chemical Abstracts Service (CAS)